Advertisement

Ads Placeholder
Loading...

Dishman Carbogen Amcis Limited

DCAL.BO•BSE
Healthcare
Biotechnology
₹147.40
₹1.50(1.03%)
Indian Market opens in 34h 48m

Dishman Carbogen Amcis Limited (DCAL.BO) Stock Overview

Explore Dishman Carbogen Amcis Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap23.1B
P/E Ratio19.40
EPS (TTM)$7.58
ROE0.02%
Fundamental Analysis

AI Price Forecasts

1 Month$181.90
3 Months$269.07
1 Year Target$266.47

DCAL.BO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Dishman Carbogen Amcis Limited (DCAL.BO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 40.93, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $266.47.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 19.40 and a market capitalization of 23.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.03%
5-Day Change
-6.05%
1-Month Change
-10.20%
3-Month Change
-42.12%
6-Month Change
-48.06%
Year-to-Date (YTD) Change
-42.63%
1-Year Change
-34.43%
3-Year Change
12.35%
5-Year Change
25.61%
All-Time (Max) Change
-58.04%

Contact Information

https://imdcal.com
91 27 1742 0102
Dishman Corporate House, Ahmedabad, NaN, 380058

Company Facts

11,320 Employees
IPO DateSep 21, 2017
CountryIN
Actively Trading

Frequently Asked Questions